An impurity of Eptifibatide. Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called RGD (arginine-glycine-aspartate)-mimetics and reversibly binds to platelets.
CAT No: 10-101-201
Eptifibatide Impurity 1 is a specialized carbohydrate compound recognized for its structural similarity to the parent molecule, eptifibatide, which is widely studied in the context of glycoprotein IIb/IIIa receptor interactions. As a distinct impurity, Eptifibatide Impurity 1 offers unique opportunities for analytical and research applications, particularly in the fields of pharmaceutical development and quality assessment. Its well-characterized structure enables researchers to investigate the presence, behavior, and impact of related substances during drug synthesis and formulation. The compound's relevance extends to method development, impurity profiling, and stability studies, making it an essential reference material in scientific laboratories focused on peptide and carbohydrate analysis. Its compatibility with advanced chromatographic and spectrometric techniques further enhances its utility in both academic and industrial research settings.
Analytical Method Development: Eptifibatide Impurity 1 serves as a critical reference standard in the development and validation of analytical methods used to detect and quantify impurities in peptide-based pharmaceuticals. By incorporating this impurity into calibration and system suitability tests, researchers can establish robust, sensitive, and selective methods that ensure the accurate identification and quantification of structurally similar compounds. This application is essential for maintaining the integrity of pharmaceutical products and for meeting rigorous research and development requirements in the early stages of drug discovery and formulation. The use of Eptifibatide Impurity 1 in analytical method development ultimately contributes to the reliability of impurity detection protocols, supporting the advancement of high-quality peptide therapeutics.
Impurity Profiling and Characterization: As a well-defined related substance, Eptifibatide Impurity 1 is integral to comprehensive impurity profiling studies. Utilizing this compound enables scientists to map the impurity landscape of peptide preparations, facilitating the identification and quantification of minor constituents that may arise during synthesis or storage. Its application in impurity profiling supports the elucidation of degradation pathways and helps researchers understand the chemical stability of eptifibatide and its analogs. By comparing chromatographic retention times and mass spectral data, laboratories can confidently distinguish between the parent drug and its impurities, thereby enhancing the accuracy of quality control processes and ensuring the consistency of research materials.
Stability Studies: The inclusion of Eptifibatide Impurity 1 in stability testing protocols allows for a deeper understanding of the degradation behavior of peptide-based compounds under various environmental conditions. Researchers can monitor the formation and persistence of this impurity during accelerated or long-term stability studies, gaining insights into the factors that influence product shelf life and chemical integrity. This knowledge is invaluable for optimizing storage conditions, packaging materials, and formulation strategies, ultimately contributing to the development of more stable and reliable pharmaceutical products. The use of this impurity as a marker for degradation also aids in the prediction and mitigation of potential stability issues during the research and development process.
Process Optimization: In the context of synthetic process development, Eptifibatide Impurity 1 provides essential information for refining manufacturing protocols and minimizing impurity formation. By tracking its presence during different stages of synthesis and purification, chemists can identify critical control points and implement targeted modifications to enhance product purity. This application supports the efficient scale-up of peptide production, reduces the risk of batch-to-batch variability, and ensures the reproducibility of research findings. The insights gained from process optimization studies using this impurity can also inform the selection of raw materials, reagents, and purification techniques, contributing to continuous improvement in peptide manufacturing.
Reference Material for Instrument Calibration: Laboratories routinely utilize Eptifibatide Impurity 1 as a reference material for the calibration and performance verification of analytical instruments such as high-performance liquid chromatography (HPLC) and mass spectrometry systems. Accurate calibration with this compound ensures the reliability and precision of quantitative analyses, supporting the generation of high-quality data for research and development projects. By maintaining consistent instrument performance, laboratories can confidently compare results across different studies and platforms, facilitating collaboration and knowledge sharing within the scientific community. The availability of a well-characterized impurity standard like Eptifibatide Impurity 1 is therefore indispensable for maintaining the rigor and reproducibility of peptide and carbohydrate research.
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.